CDE News - Your News Feed

CD Covid-19, Coronavirus, USACoronavirus, Moderna, USA, vaccine

Moderna says COVID-19 vaccine unlikely to be ready before November

Moderna Inc will not be ready to apply for emergency authorization for its potential COVID-19 vaccine before the U.S. presidential election in November, the Financial Times reported on Wednesday, citing…

Read More from CDE News

Coronavirus, GermanyCoronavirus, CureVac, Germany, vaccine

CureVac plans global late-stage COVID-19 vaccine trial

Germany's CureVac NV said it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth…

Read More from CDE News

Coronavirus, World BankCoronavirus, vaccine, world Bank

World Bank seeks board approval for $12 bln coronavirus vaccine financing plan

World Bank President David Malpass said he is seeking board approval for a $12 billion coronavirus vaccine financing plan to help poor and developing countries secure a sufficient share of…

Read More from CDE News

Coronavirus, SwitzerlandCoronavirus, novartis, vaccine

Novartis CEO says it will take more than vaccines to fight COVID

Vaccines alone will not be enough to fight Covid-19, Novartis AG Chief Executive Officer Vas Narasimhan said. Treatments will also play a crucial role. Significant supplies of highly effective vaccines…

Read More from CDE News

Coronavirus, UKCoronavirus, GlaxoSmithKline, vaccine

GlaxoSmithKline CEO optimistic COVID-19 vaccine widely available in 2021

The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.…

Read More from CDE News

CD eNews, Coronavirus, USACoronavirus, Moderna, USA, vaccine

Study shows Moderna COVID-19 vaccine appears safe, shows signs of working in older adults

Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,…

Read More from CDE News

CD eNews, Coronavirus, IndiaCoronavirus, India, vaccine

Indian PM pledges to UN that country’s vaccine will be made available globally

Indian Prime Minister Narendra Modi pledged at the United Nations on Saturday that his country's vaccine production capacity would be made available globally to fight the COVID-19 crisis. "As the…

Read More from CDE News

CD eNews, Coronavirus, USACoronavirus, Johnson & Johnson, vaccine

Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published…

Read More from CDE News

China, CoronavirusChina, Coronavirus, vaccine, WHO

China says WHO gave blessing for coronavirus vaccine emergency use programme

The World Health Organization gave China its support and understanding to start administering experimental coronavirus vaccines to people while clinical trials were still underway, a Chinese health official said on…

Read More from CDE News

CD eNews, Comuniq.eu Covid, Coronavirus, European UnionAstraZeneca, Coronavirus, European Union, vaccine

AstraZeneca gets partial immunity in low-cost EU vaccine deal

European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official…

Read More from CDE News

Coronavirus, UKCoronavirus, UK, vaccine

Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial

Pfizer's German development partner BioNTech on Thursday joined other leading COVID-19 vaccine developers in ruling out participation in British plans to test experimental inoculations by deliberately infecting trial volunteers. "BioNTech's…

Read More from CDE News

Coronavirus, RussiaCoronavirus, Russia, vaccine

Russia to supply 17 more countries with COVID-19 drug Avifavir

Russia's sovereign wealth fund and its partner Chemrar will supply the COVID-19 drug Avifavir to 17 additional countries, the fund said in a statement on Thursday. Avifavir gained approval from…

Read More from CDE News

Coronavirus, UKCoronavirus, UK, vaccine

UK volunteers to be deliberately infected with COVID-19 to test vaccine

Britain is planning to host clinical trials where volunteers are deliberately infected with the new coronavirus to test the effectiveness of vaccine candidates, the Financial Times reported on Wednesday, citing…

Read More from CDE News

CD eNews, Comuniq.eu Covid, CoronavirusEuropean Union, Novavax, vaccine

EU close to concluding preliminary talks with Novavax on COVID vaccine supply

Brussels is close to wrapping up preliminary talks with U.S. vaccine maker Novavax for its potential COVID-19 shot, an EU source involved in the negotiations said, as the bloc ramps…

Read More from CDE News

Coronavirus, USACoronavirus, USA, vaccine

U.S. FDA to tighten coronavirus vaccine authorization standards ahead of election

The U.S. Food and Drug Administration is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine, lowering the chances that one might be…

Read More from CDE News

Coronavirus, USACoronavirus, Moderna, vaccine

Moderna sees 20 million doses of COVID-19 vaccine candidate by year end

Moderna Inc announced it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500…

Read More from CDE News

Coronavirus, USACoronavirus, vaccine

How drugmakers can keep their pledge and still deliver an October vaccine surprise

As questions mount over whether the United States will authorize a coronavirus vaccine ahead of November elections, experts say there is a slim chance that enough evidence will be available…

Read More from CDE News

CD eNews, CoronavirusCoronavirus, vaccine

Only one in 10 to be protected from COVID-19 in first year of vaccine use

Sky News on Sunday reported that just one in 10 of the world's population is likely to be protected against COVID-19 in the first year of a vaccine being made…

Read More from CDE News

CD eNews, Coronavirus, USAAstraZeneca, Coronavirus, USA, vaccine

AstraZeneca says COVID-19 vaccine trial in U.S still on hold

AstraZeneca Plc said that its COVID-19 vaccine trial in the United States is still on hold. AstraZeneca on Saturday published a document describing details of how the COVID-19 vaccine trial…

Read More from CDE News

Coronavirus, Economy, HungaryCoronavirus, vaccine

Hungary’s economy hinges on vaccine discovery

Hungary's economy will struggle to grow next year if a coronavirus vaccine is not found, finance minister Mihaly Varga said in an interview published Saturday, as the government prepares to…

Read More from CDE News

Coronavirus, Election Watch, USACoronavirus, Donald Trump, vaccine

Biden contradicts Trump’s suggestion that vaccine is weeks away

U.S. Democratic presidential candidate Joe Biden on Thursday bluntly contradicted President Donald Trump's suggestion that a coronavirus vaccine may be only weeks away, warning Americans they cannot trust the president's…

Read More from CDE News

Coronavirus, FranceCoronavirus, France, vaccine, WHO

Reuters exclusive – France won’t buy vaccines through WHO’s COVAX scheme – ministry source

France will provide funding for an initiative led by the World Health Organization to buy potential COVID-19 vaccines, but will not source shots through the programme, an official at the…

Read More from CDE News

Coronavirus, RussiaCoronavirus, India, Russia, vaccine

Russia seals another deal to supply and test its coronavirus vaccine abroad

Russia's sovereign wealth fund will supply 100 million doses of its potential coronavirus vaccine to Indian drug company Dr Reddy's Laboratories , the fund announced, as Moscow speeds up plans…

Read More from CDE News

China, CoronavirusChina, Coronavirus, Sinovac, vaccine

China’s Sinovac to test coronavirus vaccine candidate in teenagers, children

Chinese vaccine maker Sinovac Biotech plans to start a clinical trial of its experimental coronavirus vaccine with children and adolescents later this month, widening its test on a shot that's…

Read More from CDE News

Coronavirus, UKAstraZeneca, UK, vaccine

AstraZeneca’s trial illnesses may not be due to COVID-19 shot – Oxford University

The adverse events that led to a pause in trials evaluating AstraZeneca Plc's COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining…

Read More from CDE News

Coronavirus, ItalyAstraZeneca, Coronavirus, Italy, vaccine

Italy could have AstraZeneca COVID-19 vaccine by end November

Italy could have its first shots of British drugmaker AstraZeneca's potential COVID-19 vaccine by the end of November, the managing director of IRBM told Reuters. Biotech firm IRBM, whose lab…

Read More from CDE News

CD eNews, Coronavirus, USACoronavirus, USA, vaccine

Trump says coronavirus vaccine could be weeks away

U.S. President Donald Trump on Tuesday said a vaccine against the deadly coronavirus could be three or four weeks away, despite cautionary notes sounded by some U.S. public health officials…

Read More from CDE News

CD Covid-19Coronavirus, Pfizer, vaccine

Pfizer says late-stage coronavirus vaccine study shows moderate side effects

Pfizer Inc said on Tuesday participants were showing mild-to-moderate side effects when given either the company's experimental coronavirus vaccine or a placebo in an ongoing late-stage study. Over 12,000 study…

Read More from CDE News

Coronavirus, GermanyCoronavirus, vaccine

Germany plans voluntary vaccination for mid-2021

Germany aims to reach herd immunity through a voluntary coronavirus vaccine expected to be widely available by mid-2021, the health minister said Tuesday. Speaking to reporters in Berlin, minister Jens…

Read More from CDE News

Coronavirus, UKCoronavirus, UK, vaccine, Valneva

Valneva to supply up to 190 million doses of COVID-19 vaccine to UK

French vaccine maker Valneva said on Monday it would supply the UK with up to 190 million doses of its coronavirus vaccine candidate, VLA2001, over a five-year period. Under the…

Read More from CDE News

CD eNews, Comuniq.EU, CoronavirusAstraZeneca, Coronavirus, UK, vaccine

EU medical register shows AstraZeneca’s UK COVID-19 vaccine trials restarted

AstraZeneca's British clinical trials of its COVID-19 vaccine, one of the most advanced in development, resumed on Monday, according to the European clinical trials database EudraCT. The trial's status changed…

Read More from CDE News

Coronavirus, World Health Organization (WHO)Coronavirus, vaccine, WHO

WHO head urges rich nations to join vaccine scheme by Friday deadline

Countries should join the World Health Organization's (WHO) COVAX vaccine facility by a Friday deadline to help ensure that immunizations are fairly and efficiently distributed, WHO Director General Tedros Adhanom…

Read More from CDE News

Coronavirus, SpainCoronavirus, Spain, vaccine

J&J unit to start mid-stage COVID-19 vaccine trials in Spain

Johnson & Johnson's Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the programme's lead investigator said. Alberto Borobia said 190 people would take part…

Read More from CDE News

Coronavirus, RussiaCoronavirus, Russia, vaccine

More than 1 billion people to get Russia’s COVID-19 vaccine in 2020-2021

Russia's sovereign wealth fund said that more than one billion people would receive its COVID-19 vaccine "Sputnik-V" in 2020-21, the Interfax news agency reported. The Russian Direct Investment Fund (RDIF)…

Read More from CDE News

Coronavirus, USACoronavirus, Merck, USA, vaccine

Merck starts recruitment for COVID-19 vaccine trial

U.S. drug maker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database clinicaltrials.gov. The phase 1/2 trial, which is based…

Read More from CDE News

Coronavirus, WHOCoronavirus, vaccine, WHO

WHO says $700 million raised so far for COVID-19 vaccines initiative for poor

International donors have raised $700 million - less than half the target - to purchase future coronavirus vaccines for poor countries in a global initiative to ensure eventual vaccines do…

Read More from CDE News

Brazil, Coronavirus, RussiaBrazil, Russia, vaccine

Russia’s RDIF agrees to manufacture Covid-19 vaccine in Brazil

Russia's sovereign wealth fund RDIF announced that it had agreed to manufacture Russia's first registered COVID-19 vaccine "Sputnik-V" in Brazil. RDIF, which is backing the vaccine's development, also said it…

Read More from CDE News

Coronavirus, News, UKCoronavirus, vaccine

Global study finds Covid vaccine confidence volatile, vulnerable to misinformation

Political polarisation and online misinformation are threatening vaccination programmes worldwide, with public trust volatile and varying widely between countries, according to a global vaccine confidence study. The study, which maps…

Read More from CDE News

CD eNews, Coronavirus, World Health Organization (WHO)AstraZeneca, Coronavirus, vaccine, WHO

AstraZeneca vaccine trial pause a “wake-up call”, says WHO

AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief…

Read More from CDE News

Brazil, CoronavirusBrazil, Coronavirus, Sinovac, vaccine

Brazil trials of Sinovac COVID-19 vaccine show promising results

The governor of Brazil’s São Paulo state said on Wednesday that Phase 3 clinical trials of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd have shown promising results…

Read More from CDE News

Coronavirus, RussiaCoronavirus, Russia, vaccine

Some scientists question Russia Sputnik-V vaccine data

Twenty-six scientists, most of them working at universities in Italy, have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian…

Read More from CDE News

CD eNews, Coronavirus, UKAstraZeneca, Coronavirus, UK, vaccine

AstraZeneca says should know if vaccine works by year-end if trials resume

AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker's chief executive Pascal Soriot said on Thursday, as long as…

Read More from CDE News

CD eNews, Coronavirus, UKAstraZeneca, Coronavirus, UK, vaccine

UK says other vaccine trials also likely to be paused

Other COVID-19 vaccine trials are likely to be paused at some point the British government’s Chief Scientific Adviser Patrick Vallance, said, describing a pause in the trial of an AstraZeneca…

Read More from CDE News

Coronavirus, IndiaCoronavirus, India, Russia, vaccine

India weighing Russian offer for Sputnik-V vaccine trial, manufacturing

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, an Indian government official said.…

Read More from CDE News

Australia, CoronavirusAstraZeneca, Australia, vaccine

Australia says not worried about AstraZeneca’s suspension of COVID vaccine trials

AstraZeneca Plc's suspension of its COVID-19 vaccine trials after a participant's unexplained illness did not mean the vaccine had been scrapped and showed safety standards were being adhered to, Australia's…

Read More from CDE News

China, CoronavirusChina, Coronavirus, vaccine

China’s CanSino defends coronavirus vaccine candidate after experts cast doubt

China's CanSino Biologics Inc said on Wednesday that expert opinion on its high-profile coronavirus vaccine candidate should not be followed "blindly" without sufficient clinical trial data. Scientists outside the company…

Read More from CDE News

Coronavirus, USACoronavirus, vaccine

Inovio partners with Thermo Fisher to bolster COVID-19 vaccine supply

Inovio Pharmaceuticals Inc announced that Thermo Fisher Scientific would manufacture the drug developer's experimental coronavirus vaccine, as it looks to boost the supply ahead of large trials this month. The…

Read More from CDE News

CD eNews, Coronavirus, WHOAstraZeneca, Coronavirus, vaccine, WHO

UPDATED: WHO says vaccine safety top priority, as AstraZeneca pauses study

Safety of a prospective vaccine for COVID-19 comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused,…

Read More from CDE News

Coronavirus, UKAstraZeneca, UK, vaccine

UK health minister says pause in AstraZeneca vaccine trial not necessarily a setback

Britain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a…

Read More from CDE News

Coronavirus, Europe, USACoronavirus, European Union, USA, vaccine

U.S., European COVID vaccine developers make pledge to uphold testing rigour

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards that their experimental immunisations will be held against, amid a hurried global race to contain…

Read More from CDE News

CD eNews, Coronavirus, UKAstraZeneca, Coronavirus, vaccine

AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concern

AstraZeneca Plc announced it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. "Our standard review process was…

Read More from CDE News

CD Covid-19Coronavirus, vaccine

Coronavirus vaccine development status update

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the coronavirus…

Read More from CDE News

Australia, CoronavirusAstraZeneca, Australia, Coronavirus, vaccine

Australia expects to receive AstraZeneca’s COVID-19 vaccine within months

Australia expects to receive its first batches of a potential COVID-19 vaccine in January, Prime Minister Scott Morrison said on Monday, as the number of new daily infections in the…

Read More from CDE News

China, Coronavirus, RussiaChina, Coronavirus, Russia, vaccine

How common cold viruses are being used in vaccines from Russia, China

The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China’s CanSino Biologics and Russia’s Gamaleya Institute have been studied for decades, but are still not widely used. The…

Read More from CDE News

China, CoronavirusChina, Coronavirus, Sinovac, vaccine

90% of China’s Sinovac employees, families took coronavirus vaccine

About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country's emergency use programme, its chief executive…

Read More from CDE News